Adaptive evaluation of mHealth and conventional adherence support interventions to optimize outcomes with new treatment regimens for drug-resistant tuberculosis and HIV in South Africa (ADAP-TIV): study protocol for an adaptive randomized controlled trial

Abstract Background Highly effective, short-course, bedaquiline-containing treatment regimens for multidrug-resistant tuberculosis (MDR-TB) and integrase strand transfer inhibitor (INSTI)-containing fixed dose combination antiretroviral therapy (ART) have radically transformed treatment for MDR-TB a...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Jesse Ross, Rubeshan Perumal, Allison Wolf, Mbali Zulu, Kevin Guzman, Boitumelo Seepamore, Karl Reis, Hlengiwe Nyilana, Senzo Hlathi, Radhamoney Narasimmulu, Ying Kuen K. Cheung, K. Rivet Amico, Gerald Friedland, Amrita Daftary, Jennifer R. Zelnick, Kogieleum Naidoo, Max R. O’Donnell
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	BMC 2023-12-01
Serie:	Trials
Soggetti:	Tuberculosis MDR-TB HIV/AIDS Bedaquiline Antiretrovirals mHealth
Accesso online:	https://doi.org/10.1186/s13063-023-07520-9
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!